H.C. Wainwright Reiterates Buy Rating on Cartesian Therapeutics (RNAC)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: RNAC) | Delayed: 6.27 -0.31 (4.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.58 | 52 Week High | $ | |||
| Open | $6.62 | 52 Week Low | $ | |||
| Day High | $6.65 | P/E | N/A | |||
| Day Low | $6.25 | EPS | $ | |||
| Volume | 112,780 | |||||
